Akorn, Inc. is recalling approximately 630,563 unit dose cups of Chlorhexidine Gluconate Oral Rinse (0.12%) and oral care kits containing the rinse because the medication is subpotent. The drug has shown product crystallization and out-of-specification results, meaning it does not contain the correct amount of the active ingredient needed to be effective. These products were distributed nationwide across the United States in various kit formats and individual dose cups.
The crystallization of the drug leads to a lower-than-intended concentration of chlorhexidine. This subpotency means the oral rinse may not effectively reduce bacteria in the mouth as intended, potentially failing to provide the expected therapeutic benefit to the patient.
Contact healthcare provider and return product.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.